Market Cap (In USD)
125.37 Billion
Revenue (In USD)
45 Billion
Net Income (In USD)
8.02 Billion
Avg. Volume
2.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 701.0-1225.0
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- US1101222073
- CUSIP
- -
- CIK
- 14272
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Employee Count
- -
- Website
- -
- Ipo Date
- 2003-12-08
- Details
- Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
More Stocks
-
002044
-
3540
-
2458
-
003009
-
023590Daou Technology Inc.
023590
-
QCA
-
1926
-
2426Tyntek Corporation
2426